Increased risk of anti-drug antibodies to a second anti-TNF in patients who developed antibodies to the first anti-TNF

被引：0
|
作者：
Yanai, H. [1 ,2 ]
Amir, S. [2 ]
Biron, I. Avni [1 ,2 ]
Perets, T. Tsadok [1 ,2 ]
Shamir, R. [2 ,3 ]
Dotan, I. [1 ,2 ]
Assa, A. [2 ,3 ]
机构：
[1] Rabin Med Ctr, IBD Ctr, Div Gastroenterol, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Schneider Childrens Med Ctr, Inst Gastroenterol Nutr & Liver Dis, Petah Tiqwa, Israel
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P506
引用
收藏
页码：S439 / S439
页数：1
相关论文
共 50 条
  • [1] INCREASED RISK OF ANTI-DRUG ANTIBODIES TO A SECOND ANTI-TNF IN PATIENTS WHO DEVELOPED ANTIBODIES TO THE FIRST ANTI-TNF
    Yanai, Henit A.
    Amir, Shira
    Avni-Biron, Irit
    Perets, Tsachi Tsadok
    Shamir, Raanan
    Dotan, Iris
    Assa, Amit
    GASTROENTEROLOGY, 2020, 158 (06) : S671 - S671
  • [2] ANTI-DRUG ANTIBODIES AS A PREDICTOR FOR THE DISCONTINUATION OF ANTI-TNF AGENTS IN PATIENTS WITH SPONDYLOARTHRTIS
    Kim, H. J.
    Hwang, J.
    Kim, I.
    Jeong, H.
    Lee, J.
    Jeon, C. H.
    Koh, E. -M.
    Cha, H. -S.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 717 - 718
  • [3] ANTI-DRUG ANTIBODIES: ASSAY PERFORMANCE IN PATIENTS TREATED WITH ANTI-TNF BIODRUGS
    Hock, B.
    O'donnell, J. L.
    Liu, J.
    Keating, P.
    Spellerberg, M.
    Stamp, L.
    Barclay, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1415 - 1415
  • [4] LOW DRUG CONCENTRATIONS AND ANTI-DRUG ANTIBODY FORMATION TO THE PRIOR ANTI-TNF PREDISPOSES PATIENTS WITH INFLAMMATORY BOWEL DISEASE TO DEVELOP ANTI-DRUG ANTIBODIES TO THE SUBSEQUENT ANTI-TNF
    Cheifetz, Adam S.
    Abreu, Maria T.
    Flier, Sarah N.
    Papamichail, Konstantinos
    Rieder, Florian
    Silverberg, Mark S.
    Khanna, Reena
    Okada, Lauren
    Yang, Lei
    Jain, Anjali
    Vande Casteele, Niels
    GASTROENTEROLOGY, 2020, 158 (06) : S457 - S457
  • [5] Anti-Drug Antibodies As a Predictor for the Discontinuation of Anti-TNF Agents in Patients with Spondyloarthrtis.
    Hwang, Jiwon
    Kim, In Young
    Lee, Seulkee
    Jeong, Hyemin
    Kim, Hyungjin
    Lee, Jaejoon
    Koh, Eun-mi
    Cha, Hoon-Suk
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S263 - S263
  • [6] Prior Immunogenicity to Anti-TNF Biologics Is Not Associated with Increased Anti-drug Antibodies to Vedolizumab or Ustekinumab
    Nicholas J. Costable
    Zachary A. Borman
    Jiayi Ji
    Marla C. Dubinsky
    Ryan C. Ungaro
    Digestive Diseases and Sciences, 2022, 67 : 2480 - 2484
  • [7] PRIOR IMMUNOGENICITY TO ANTI-TNF BIOLOGICS IS NOT ASSOCIATED WITH INCREASED ANTI-DRUG ANTIBODIES TO VEDOLIZUMAB OR USTEKINUMAB
    Costable, Nicholas J.
    Borman, Zachary A.
    Phan, Becky L.
    Ji, Jiayi
    Dubinsky, Marla
    Ungaro, Ryan C.
    GASTROENTEROLOGY, 2020, 158 (06) : S468 - S469
  • [8] Prior Immunogenicity to Anti-TNF Biologics Is Not Associated with Increased Anti-drug Antibodies to Vedolizumab or Ustekinumab
    Costable, Nicholas J.
    Borman, Zachary A.
    Ji, Jiayi
    Dubinsky, Marla C.
    Ungaro, Ryan C.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (06) : 2480 - 2484
  • [9] INCREASED FREQUENCY OF ANTI-DRUG ANTIBODIES IN PATIENTS CARRYING COMPATIBLE IGG1 ALLOTYPES AND TREATED WITH ANTI-TNF ANTIBODIES
    Lopez-Rodriguez, R.
    Martinez, A.
    Plasencia, C.
    Jochems, A.
    Pascual-Salcedo, D.
    Balsa, A.
    Gonzalez, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 59 - 59
  • [10] Increased Frequency of Anti-Drug Antibodies in Patients Carrying Compatible IgG1 Allotypes and Treated with Anti-TNF Antibodies
    Gonzalez, Antonio
    Lopez-Rodriguez, Rosario
    Martinez, Ana
    Plasencia-Rodriguez, Chamaida
    Jochems, Andrea
    Pascual-Salcedo, Dora
    Balsa, Alejandro
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345